Splicing inhibition induces gene expression through canonical NF‐κB pathway and extracellular signal‐related kinase activation
暂无分享,去创建一个
N. Mukaida | Minoru Yoshida | A. Ito | Rei Yoshimoto | Tilman Schneider-Poetsch | M. Ishfaq | Khalid Khan | Tilman Schneider‐Poetsch
[1] T. Bonfield,et al. Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cells , 2011, Journal of Inflammation.
[2] S. Kojima,et al. Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF , 2010, Cancer science.
[3] A. S. Shifera,et al. PMA induces expression from the herpes simplex virus thymidine kinase promoter via the activation of JNK and ERK in the presence of adenoviral E1A proteins. , 2009, Archives of biochemistry and biophysics.
[4] C. Will,et al. The Spliceosome: Design Principles of a Dynamic RNP Machine , 2009, Cell.
[5] D. Waugh,et al. The Interleukin-8 Pathway in Cancer , 2008, Clinical Cancer Research.
[6] M. Hagiwara,et al. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA , 2007, Nature Chemical Biology.
[7] Jingfeng Li,et al. Parthenolide Inhibits IκB Kinase, NF-κB Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice , 2007 .
[8] G. Weber,et al. Synergistic activation of the CMV promoter by NF-κB P50 and PKG , 2004 .
[9] P. Brecher,et al. Temporal Control of NF-κB Activation by ERK Differentially Regulates Interleukin-1β-induced Gene Expression* , 2004, Journal of Biological Chemistry.
[10] S. Horinouchi,et al. Structure-activity Relationship for FR901464: A Versatile Method for the Conversion and Preparation of Biologically Active Biotinylated Probes , 2004, Bioscience, biotechnology, and biochemistry.
[11] O. Dittrich‐Breiholz,et al. Multiple control of interleukin‐8 gene expression , 2002, Journal of leukocyte biology.
[12] P. Bennett,et al. Nuclear factor-kappa B is essential for up-regulation of interleukin-8 expression in human amnion and cervical epithelial cells. , 2001, Molecular human reproduction.
[13] J. Metcalf,et al. Adenovirus Type 7 Induces Interleukin-8 Production via Activation of Extracellular Regulated Kinase 1/2 , 2001, Journal of Virology.
[14] T. Hofmann,et al. The Antiinflammatory Sesquiterpene Lactone Parthenolide Inhibits NF-κB by Targeting the IκB Kinase Complex , 1999, The Journal of Immunology.
[15] S. Horinouchi,et al. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase , 1999, Oncogene.
[16] K. Matsushima,et al. Human T-Cell Leukemia Virus Type I Tax Transactivates Human Interleukin 8 Gene through Acting Concurrently on AP-1 and Nuclear Factor-κB-like Sites , 1998 .
[17] Harry F Noller,et al. Molecular Movement inside the Translational Engine , 1998, Cell.
[18] M. Okuhara,et al. New antitumor substances, FR901463, FR901464 and FR901465. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities. , 1997, The Journal of antibiotics.
[19] M. Okuhara,et al. New Antitumor Substances, FR901463, FR901464 and FR901465 , 1996 .
[20] M. Okuhara,et al. New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. , 1996, The Journal of antibiotics.
[21] P. Baeuerle,et al. A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B. , 1994, The EMBO journal.
[22] H. Volk,et al. Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. , 1993, The Journal of general virology.
[23] P. Corthésy,et al. Interleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell line , 1989, European journal of immunology.
[24] M. Karin,et al. Phorbol ester induces the transcriptional stimulatory activity of the SV40 enhancer , 1986, Nature.
[25] Jingfeng Li,et al. Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. , 2007, American journal of respiratory cell and molecular biology.
[26] P. Brecher,et al. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. , 2004, Journal of Biological Chemistry.
[27] G. Weber,et al. Synergistic activation of the CMV promoter by NF-kappaB P50 and PKG. , 2004, Biochemical and biophysical research communications.
[28] T. Hofmann,et al. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. , 1999, Journal of immunology.
[29] F. Lee,et al. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. , 1999, The Journal of biological chemistry.
[30] K. Matsushima,et al. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. , 1998, Cancer research.